By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Personal Genome Diagnostics 

2809 Boston St, Suite 503

Baltimore   Maryland  21224 
Phone: 443-602-8833 Fax: n/a



Company News
Personal Genome Diagnostics' Expanded PlasmaSELECT 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel To Include MSI Analyses For Immuno-Oncology 3/28/2017 7:30:37 AM
Personal Genome Diagnostics Announces Expanded Cancer Testing Contract With U.S. Department Of Veteran Affairs 3/22/2017 9:41:21 AM
Personal Genome Diagnostics Awarded NCI Contract To Develop Novel Diagnostic For Immuno-Oncology Drugs 2/1/2017 9:14:03 AM
Personal Genome Diagnostics Release: Company Adds James Lewis As Senior Vice President Of Corporate Development 1/17/2017 9:09:05 AM
Personal Genome Diagnostics' ImmunoSELECT Technology Demonstrates How Resistance To Checkpoint Blockade Therapy Evolves In Cancer Discovery Study 1/4/2017 1:36:37 PM
Personal Genome Diagnostics Launches CancerSELECT 125 Test For Pan-Cancer Tumor Profiling 12/19/2016 11:02:53 AM
Personal Genome Diagnostics Launches RNAcomplete Allowing Co-Extraction And Analysis Of RNA And DNA From A Single FFPE Tissue Sample 10/24/2016 7:59:40 AM
Personal Genome Diagnostics Licenses Rights To Microsatellite Instability (MSI) Testing Technology From Johns Hopkins University To Inform Immunotherapy 10/20/2016 8:27:26 AM
Personal Genome Diagnostics Launches PlasmaSELECT 64 Panel For Non-Invasive Pan-Cancer Tumor Profiling 10/4/2016 8:02:55 AM
Personal Genome Diagnostics Reports Positive Data On Utility Of Liquid Biopsy Testing In Small Cell Lung Cancer Patients 9/14/2016 7:06:34 AM